. Author manuscript; available in PMC: 2016 Jul 1.

Published in final edited form as: Lancet Neurol. 2015 May 27;14(7):710–719. doi: 10.1016/S1474-4422(15)00058-7

Table 3.

Univariate Cox Regression Analysis for time to death as outcome

Symptom	N	p-value^*	Hazard Ratio	95^th Confidence Interval
Age	175	0.8151	1.019	.995 – 1.043
Gender	175	0.8151	0.867	.581 – 1.294
Urinary incontinence	175	0.8151	1.186	.597 – 2.355
Fecal incontinence	175	0.8151	0.779	.508 – 1.194
Incomplete bladder emptying	175	0.858	0.923	.531 – 1.606
Parkinsonism onset	175	0.8151	1.397	.567 – 3.444
Cerebellar (ataxia) onset	175	1.000	1.000	.672 – 1.487
Levodopa responsiveness	124	0.8151	0.708	.442 – 1.132
Pyramidal signs	175	0.8151	0.896	.607 – 1.322
Babinski sign	175	0.858	0.947	.634 – 1.417
Hyperreflexia	175	0.8151	0.835	.557 – 1.251
UMSARS I score ≥ 25	175	0.8151	1.245	.816 – 1.898
UMSARS II score ≥ 25	175	0.8151	1.129	.747 – 1.707

Multiple comparison adjusted p-values reported use false discovery rate approach.